ZBP1 and breast cancer: This study introduces an innovative sono‐controllable Janus hydrogel platform, GA@CaMP, which integrates precise US‐mediated ROS release control, ZBP1 gene regulation, and the improvement of the hypoxic microenvironment, to address both tumor treatment and bone regeneration in breast cancer bone metastasis.